Tema Heart & Health ETF (NASDAQ:HRTS) Shares Up 1.3% – Time to Buy?

Shares of Tema Heart & Health ETF (NASDAQ:HRTS) traded up 1.3% during mid-day trading on Wednesday . The stock traded as high as $33.37 and last traded at $33.21. 1,443 shares changed hands during trading, a decline of 79% from the average session volume of 6,966 shares. The stock had previously closed at $32.77.

Tema Heart & Health ETF Price Performance

The firm has a 50-day moving average price of $35.14 and a 200 day moving average price of $34.08. The company has a market cap of $51.82 million, a price-to-earnings ratio of 22.06 and a beta of 0.97.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in HRTS. Kestra Advisory Services LLC bought a new stake in shares of Tema Heart & Health ETF in the fourth quarter valued at about $27,000. JPMorgan Chase & Co. acquired a new stake in Tema Heart & Health ETF in the 2nd quarter worth about $63,000. Citadel Advisors LLC bought a new stake in Tema Heart & Health ETF in the 3rd quarter valued at about $243,000. Brookstone Capital Management acquired a new position in shares of Tema Heart & Health ETF during the 4th quarter worth approximately $364,000. Finally, Jane Street Group LLC grew its position in shares of Tema Heart & Health ETF by 9.4% during the 2nd quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock worth $1,062,000 after purchasing an additional 3,202 shares in the last quarter.

Tema Heart & Health ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.